Blockticity Launches Avalanche-Powered L1 to Authenticate $1.2B+ in Global Trade

Blockticity, a blockchain and AI platform securing global trade documents, has launched a custom Avalanche Layer 1 network via AvaCloud. This marks a major shift in trade infrastructure-migrating 45,000 Certificates of Authenticity (COAs) from Avalanche C-Chain and minting 700,000 new COAs on its dedicated mainnet. Combined, these assets represent over $1.2 billion in authenticated real-world […]

ParaZero Technologies Strengthens U.S. Drone Leadership with Innovative Solutions in Live U.S. Demonstration

(NASDAQ:PRZO), Kfar Saba, Israel, June 12, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, announces its participation in recent live demonstrations and strategic engagements in the U.S. that underscore its commitment to advancing drone

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

(NASDAQ:BNTX), Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech's next key milestone in the execution of its oncology strategy Acquisition of CureVac will complement BioNTech's capabilities and proprietary technologies in mRNA design, delivery formulations, and mRNA manufacturing Public exchange offer for all shares of CureVac where each

ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it has entered into securities purchase agreements for the sale of its equity securities to certain institutional investors in a $100.0 million private investment in public equity (“PIPE”) financing. In the PIPE, ADC

CNX Announces Promotion of Alan Shepard to President

CNX Resources Corporation (NYSE: CNX) announces the promotion of Alan Shepard to the position of President in addition to his current role as Chief Financial Officer. “The opportunity set for the CNX team to continue to create per-share value for our owners and to positively transform our Appalachian communities has never been greater,” said Nick

TELUS Submits Non-Binding Indication of Interest to Acquire Full Ownership of TELUS Digital

Acquisition would offer TELUS Digital shareholders liquidity at a compelling value and enhance TELUS Digital's ability to effectively respond to changing market dynamics Closer operational integration between TELUS and TELUS Digital to supercharge AI and SaaS transformation across telecommunications, health, agriculture and consumer goods sectors TELUS Digital to continue as a key enabler to TELUS'

Cardinal Health Details Momentum and Updated Long-Term Value Creation Plans at Investor Day

Key announcements: — Raising FY25 non-GAAP diluted EPS guidance to $8.15 to $8.201 — Establishing preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30 (13% growth at the mid-points)2 — Confirming long-term target of 12% to 14% non-GAAP diluted EPS CAGR for FY26 to FY283 — Raising long-term target for Pharmaceutical and Specialty Solutions

ParaZero Technologies Strengthens U.S. Drone Leadership with Innovative Solutions in Live U.S. Demonstration

ParaZero Technologies Strengthens U.S. Drone Leadership with Innovative Solutions in Live U.S. Demonstration GlobeNewswire June 12, 2025 Kfar Saba, Israel, June 12, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, announces its participation in

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer GlobeNewswire June 12, 2025 Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech's next key milestone in the execution of its oncology strategy Acquisition of CureVac will complement BioNTech's capabilities and proprietary technologies in mRNA design, delivery

HTX Launches TRX Options, Empowering Users with Flexible and Diversified Trading Strategies

SINGAPORE, June 12, 2025 (GLOBE NEWSWIRE) — HTX, a leading global cryptocurrency exchange, officially launched its highly anticipated TRX options products on June 11, further enhancing its robust derivatives offerings. This development provides users with greater trading flexibility and additional tools to manage risk and pursue profit in a dynamic market environment. The introduction of

Scroll to Top